CONSENT, JOINDER AND AMENDMENT NO. 2 TO LOAN AND SECURITY AGREEMENTLoan and Security Agreement • February 14th, 2022 • Aytu Biopharma, Inc • Pharmaceutical preparations • New York
This Loan and Security Agreement (as it may be amended, restated or otherwise modified from time to time, this "Agreement") is entered into on October 2, 2019, by and among NEOS THERAPEUTICS, INC., a Delaware corporation ("Company"), NEOS THERAPEUTICS BRANDS, LLC, a Delaware limited liability company ("NT Brands"), NEOS THERAPEUTICS, LP, a Texas limited partnership ("NT LP"; together with Company, NT Brands and each other Person who joins this Agreement as a borrower from time to time, each a "Borrower" and collectively the "Borrowers"), NEOS THERAPEUTICS COMMERCIAL, LLC, a Delaware limited liability company ("NT Commercial"), and PHARMAFAB TEXAS, LLC, a Texas limited liability company ("NT PharmaFab"), as Loan Party Obligors (as defined herein), the Lenders party hereto from time to time and ECLIPSE BUSINESS CAPITAL LLC (F/K/A ENCINA BUSINESS CREDIT, LLC), as agent for the Lenders (in such capacity, "Agent"). The Schedules and Exhibits to this Agreement are an integral part of this Ag
EMPLOYMENT AGREEMENTEmployment Agreement • February 14th, 2022 • Aytu Biopharma, Inc • Pharmaceutical preparations • Colorado
This Employment Agreement (the "Agreement"), is effective as of January 17, 2022 (the “Effective Date”), between Aytu BioPharma, Inc., a Delaware corporation headquartered at 373 Inverness Parkway, Suite 206, Englewood, CO 80112 USA, hereinafter referred to as the "Company"), and Mark Oki (“Executive").
LOAN AND SECURITY AGREEMENT Dated as of January 26, 2022 among Aytu BioPharma, Inc., a Delaware corporation, and, together with each other party executing a signature page here to as such, individually and collectively, jointly and severally, and...Loan and Security Agreement • February 14th, 2022 • Aytu Biopharma, Inc • Pharmaceutical preparations • California
Borrower, Lenders and Agent have entered or anticipate entering into one or more transactions pursuant to which each Lender agrees to make available to Borrower a loan facility governed by the terms and conditions set forth in this document and one or more Supplements executed by Borrower, Lenders and Agent which incorporate this document by reference. Each Supplement constitutes a supplement to and forms part of this document, and will be read and construed as one with this document, so that this document and the Supplement constitute a single agreement between the parties (collectively referred to as this “Agreement”).
RESTRICTED STOCK AWARD AGREEMENTRestricted Stock Award Agreement • February 14th, 2022 • Aytu Biopharma, Inc • Pharmaceutical preparations • Delaware
This RESTRICTED STOCK AWARD AGREEMENT (the “Agreement”) is made and entered into as of January 17, 2022, (the “Grant Date”), by and between Aytu BioPharma, Inc., a Delaware corporation (the “Company”), and Mark Oki (the “Grantee”).
REGISTRATION RIGHTS AGREEMENTRegistration Rights Agreement • February 14th, 2022 • Aytu Biopharma, Inc • Pharmaceutical preparations
This Agreement is made pursuant to the Warrant to Purchase Shares of Stock of Aytu BioPharma, Inc., dated as of the date hereof, between the Company and each Warrant Holder (the “Warrant Agreement”).
